LCC In Italian--First-Line Treatment Options for EGFR Mutant NSCLC Lung Cancer Considered

This episode of Lung Cancer Considered discusses first-line treatment options for EGFR mutant NSCLC, in Italian.

Guest: Dr. Jessica Menis is a thoracic medical oncologist with expertise in early-phase trials and drug development from Azienda Ospedaliera Universitaria Integrata Verona. Jessica, welcome to the podcast.


Guest: Professor Filippo de Marinis is from Istituto Europeo di Oncologia, where he is Direttore della Divisione di Oncologia Toracica, and the president of Associazione Italiana Oncologia Toracica.